Brandon Lujan, MD
Retina Specialist · Portland, ORNPI 1093722258
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $28,895 of the $32,558 with a category attached, or 88.7%. 6 manufacturers reported payments, led by Genentech, Inc. at 30.2% of the total. Reporting peaked in 2020 at $19,061 and has fallen 99.3% since, to $142 in 2023.
Across 28 payments — averaging $1162.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$10K
- Regeneron Healthcare Solutions, Inc.$9K
- Novartis Pharma AG$7K
- Genentech USA, Inc.$7K
- Novartis$72
- Carl Zeiss Meditec, Inc.$70
Across 16 payments — averaging $7513.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$76K
- Novartis Pharma AG$44K
What the payments were for
- Consulting fees$28,89589%
- Travel & lodging$2,2587%
- Food & beverage$1,4054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 14 | $9,844 |
| Regeneron Healthcare Solutions, Inc. | 4 | $8,640 |
| Novartis Pharma AG | 1 | $7,175 |
| Genentech USA, Inc. | 7 | $6,757 |
| Novartis | 1 | $72 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lucentis$14,761
- EYLEA$8,640
- BVU_BEOVU_OPHTHALMOLOGY$7,175
- Non-Covered Product$1,139
- VABYSMO$142
How this compares
$32,558 in reported general payments places this provider in the 85th percentile of 36 retina specialist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Portland
- Brian Chan KaiPortland$155K
- Andreas LauerPortland$17K
- Sirichai PasadhikaPortland$6K
- David WilsonPortland$5K
- Harpal SandhuPortland$3K
- Aristomenis ThanosPortland$3K
- Michael LeePortland$3K
- Paul TlucekPortland$2K
- Kavita BhavsarPortland$2K
- Apurva PatelPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.